Medtronic Gets Green Light For Expanded TAVR Trial
This article was originally published in The Gray Sheet
Executive Summary
Enrollment for the expanded-indication trial of Medtronic's CoreValve Evolut R transcatheter aortic valve replacement system is expected to begin in the second quarter of 2016.